Atlas Trials

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

Clinical trial NCT00519896 · COMPLETED

Trial details

NCT number
NCT00519896
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid CancerStage IVB Follicular Thyroid CancerStage IVB Papillary Thyroid CancerStage IVC Follicular Thyroid CancerStage IVC Papillary Thyroid CancerThyroid Gland Medullary Carcinoma
Start date
2007-07-01
Primary completion
2015-05-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.